|
# |
mnemonic |
QUESTION TEXT |
RESPONSE |
DEFINITIONS/DECISION RULES |
|
|
|
|
|
|
|
1 |
dcfromi |
Enter
the discharge date from the most recent hospitalization for acute myocardial
infarction. |
mm/dd/yyyy |
|
|
2 |
lipid3 |
Within
the past year, was a lipid profile, to include total cholesterol,
triglycerides, HDL-C, and LDL-C obtained for this patient? |
1*,2 *If 1, go to lipidt, else go to lip2yr |
|
|
3 |
lip2yr |
Was
a lipid profile, to include all components, done within the past two years? |
1,2* *If 2, go to onasa, else go to lipidt |
|
|
4 |
lipidt |
Enter
the date of the most recent lipid profile obtained for this patient. |
mm/dd/yyyy |
Day may be entered as 01, if exact date is unknown. At a minimum, the month and year must be entered accurately. |
|
5 |
ldlcalc |
1,2,3* *If 3, go to totalc, else go
to ldlclvl2 |
LDL
cholesterol is most commonly estimated from quantitative measurements of
total and HDL-cholesterol and plasma triglycerides (TG) using the empirical
relationship of Friedewald et al.
This method of measurement
generally requires a 12-hour fast. If
lab report does not indicate direct or calculated, ask the Liaison to find
out from the laboratory how LDL cholesterol measurement is obtained in this
particular facility. If
fasting triglycerides are over 400, and LDL-C value is noted to be invalid,
answer “3.” |
|
|
6 |
ldlclvl2 |
_____ |
Normal range is usually 60 – 130 mg/dl or less than 3.36 mmol/L (although this varies depending on the way the LDL is calculated, if it is not a direct measurement.) |
|
# |
mnemonic |
QUESTION TEXT |
RESPONSE |
DEFINITIONS/DECISION RULES |
|
|
|
|
|
|
|
7 |
ldl2unit |
Enter
the LDL-C unit of measurement: 1= mg/dL |
1,2 |
This data must be taken from the lab report in order to
ensure the correct unit of measurement is linked to the LDL-C value. |
|
8 |
totalc |
Enter
the total cholesterol value obtained as part of the lipid profile. |
_____ |
Value is generally reported as
mg/dl or mmol/L and the normal range is usually less than 200mg/dl or 5.18
mmol/L. |
|
9 |
totalunt |
Enter
the total cholesterol unit of measurement: 1= mg/dL 2 = mMol/L |
1,2 |
This data must be taken from the lab report in order to ensure the correct unit of measurement is linked to the total cholesterol value. |
|
10 |
hdlval |
Enter
HDL cholesterol value obtained as part of the lipid profile. |
_____ |
Value is generally reported as mg/dl or mmol/L and the
normal findings are usually greater than 45 mg/dl (1.17 mmol/L) in males or
55 mg/dl (1.42 mmol/L) in females. |
|
11 |
hdlunit |
Enter
the HDL cholesterol unit of measurement: 1= mg/dL 2 = mMol/L |
1,2 |
This data must be taken from the lab report in order to
ensure the correct unit of measurement is linked to the HDL-C value. |
|
12 |
trivalue |
_____ |
Normal findings are usually <180 mg/dL (2.01 mmol/L) in females and <190 mg/dL (2.12 mmol/L ) in males. |
|
|
13 |
triunit |
Enter
the triglyceride unit of measurement: 1= mg/dL 2 = mMol/L |
1,2 |
This data must be taken from the lab report in order to
ensure the correct unit of measurement is linked to the triglyceride value. |
|
14 |
onasa |
At the most recent outpatient visit,
was aspirin included in the patient’s current medications? |
1*,2 *If 1, go to betablkr, else go to notasa |
“Included in the patient’s current
medications” = ASA was listed as one of the medications the patient is taking
routinely or aspirin was prescribed at this visit. If it is noted in the paper or electronic record at least once within the past six months that the patient is taking aspirin, this is acceptable documentation of “aspirin at the most recent outpatient visit.” “Within the past six months” = from the last day of the study interval to the first day of the month six months previously. (Example: end of study interval is1/31/03. Within the past six months is from 8/1/02 – 1/31/03.). If patient was on clopidogrel (Plavix) or ticlopidine hydrochloride (Ticlid), answer “2” to this question and follow “Definitions/Decision Rules” for question “notasa.” |
|
# |
mnemonic |
RESPONSE |
||
|
|
|
|
|
|
|
15 |
notasa |
Does
the record document one or more of the following contraindications to aspirin
or other anti-platelet therapy? 2.
active bleeding at the time of the outpatient visit 3.
taking warfarin/Coumadin 4.
other reason documented by MD, NP, or PA 6. no documented contraindication |
1,2,3,4,5,6 |
When there is documentation of an aspirin “allergy” or
“sensitivity,” regard this as documentation of aspirin allergy regardless of
what type of reaction might be noted.
History of allergy, sensitivity, reaction, or intolerance to aspirin
also includes medications that contain aspirin. If
warfarin (Coumadin) is listed in patient medications, the contraindication is
met. If patient is on on
clopidogrel (Plavix) or ticlopidine hydrochloride (Ticlid), enter response #4
if one of these drugs is listed among the patient’s medications. Other
reason(s) documented by MD, NP, or PA must be explicitly documented or
clearly implied (Examples: “Chronic hepatitis – no ASA.” “May start ASA after GI bleed
resolves.” If reasons are no
mentioned in the context of aspirin, do not make inferences, e.g., Do not
assume that aspirin is not prescribed because of physician notation of
history of PUD. |
|
16 |
betablkr |
At
the most recent outpatient visit, was a beta-blocker included in the
patient’s current medications? |
1*,2
*If 1, go to wichbeta, else go to nobetab |
“Included in the
patient’s current medications” = a beta-blocker was listed as one of the
medications the patient is taking routinely or a beta-blocker was prescribed
at this visit If the most recent outpatient visit was for a specialized examination or purpose, e.g., audiology, ophthalmology, podiatry, etc., in which current medications may not be referenced, look at one or more previous outpatient visits to determine the patient’s medication regime. |
|
# |
mnemonic |
RESPONSE |
||
|
|
|
|
|
|
|
17 |
nobetab |
5. Other reasons documented by an MD, NP, or PA for not prescribing a beta blocker 6. No documented contraindication |
1,2,3,4,5,6 Go to lipdlowr |
Contraindication = a factor or condition that renders the administration of a drug or agent or the performance of a procedure or other practice inadvisable, improper, and/or undesirable. Option Rules: Beta blocker allergy = must be specific reference in the record to allergy or intolerance to beta-blockers Bradycardia = must be documented by a clinician as the reason for non-use of a beta blocker Second or third degree heart block = Do not attempt to use the EKG tracing to answer this question. The EKG interpretation of second or third degree heart block must be documented in the record by a clinician or by electronic interpretation. Documentation of the EKG interpretation does not have to be linked specifically to contraindication to beta-blocker. Systolic blood pressure = must be documented by a clinician as the reason for non-use of a beta blocker Other reasons = MD, NP, or PA documentation must explicitly link the noted reason with non-prescription of a beta-blocker COPD listed as a diagnosis is not a specific
contraindication to beta-blocker therapy.
There must be clinician documentation that beta-blockers have not been
prescribed for this patient due to his/her COPD or asthma. |
|
# |
mnemonic |
RESPONSE |
||
|
|
|
|
|
|
|
18 |
wichbeta |
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17, |
Beta blocker
generic names are not capitalized.
Brand names are capitalized. Enter the number
corresponding to the generic name documented in the medical record. Question is
applicable to the beta blocker being taken or prescribed at the time of the
most recent visit. If the patient’s
beta blocker medication was changed at the most recent visit, use the newly
prescribed medication. |
|
# |
mnemonic |
RESPONSE |
||
|
19 |
bbdose |
1,2,3 |
|
|
|
20 |
lipdlowr |
Within the past two years, was the patient on lipid-lowering medication? |
1,2* *If 2, go to cardvise, else go to medname |
“Taking or prescribed” = lipid-lowing medication was
listed among the patient’s medications within the past two years or was
prescribed at a clinic visit or inpatient admission Question does not
reference a new prescription. The
patient can have been on lipid-lowering medication for many years. Classifications of lipid-lowering medication=HMG Co-A
reductase inhibitors (statins), niacin, bile acid resins, and fibrates. |
|
# |
mnemonic |
RESPONSE |
||
|
|
|
|
|
|
|
21 |
medname |
Designate all lipid-lowering medications the patient was taking at the most recent clinic visit: Statins: 1. fluvastatin sodium (Lescol) 2. atorvastatin calcium (Lipitor) 3. lovastatin (Mevacor) 4. pravastatin sodium (Pravachol) 5. simvastatin (Zocor) Niacin: 6. niacin extended release tablets (Niaspan) Bile Acid
Resin: 7. colestipol hydrochloride (Colestid) 8. colesevelam hydrochloride (Welchol) Fibrates: 9. clofibrate (Atromid-S) 10. gemfibrozil (Lopid) 11. fenofibrate (Tricor) 12. patient not taking any of these meds at most recent visit 13. Chloride salt of basic anion exchange resin |
1,2,3,4,5,6,7,8, |
Note that although
the previous question asks about lipid-lowering medication in the past two
years, this question references the most recent visit prior to the pull list
date. More than one
lipid-lowering drug may be designated by the abstractor if the patient is on
multiple medications for dyslipidemia. |